Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 1.000 | definitive | 0.984 | 375 | 155 | 1995 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.700 | strong | 0.987 | 158 | 32 | 1995 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
phenotype | 0.200 | None | 0.966 | 117 | 17 | 1995 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.100 | None | 0.960 | 25 | 8 | 2000 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.200 | None | 1.000 | 22 | 3 | 2001 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.400 | None | 1.000 | 16 | 3 | 2007 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
group | 0.070 | None | 1.000 | 7 | 3 | 2004 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.060 | None | 1.000 | 6 | 6 | 2007 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2013 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.500 | None | 1.000 | 38 | 11 | 2005 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
group | 0.100 | None | 1.000 | 18 | 4 | 2001 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.400 | None | 1.000 | 14 | 3 | 2005 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.100 | None | 1.000 | 13 | 6 | 2005 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
phenotype | 0.100 | None | 1.000 | 7 | 7 | 2010 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.360 | strong | 0.857 | 7 | 0 | 2008 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
phenotype | 0.170 | None | 1.000 | 7 | 2 | 2009 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
phenotype | 0.170 | None | 1.000 | 7 | 5 | 2002 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
phenotype | 0.100 | None | 1.000 | 5 | 6 | 2009 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2012 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2012 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2011 | 2019 |